Andrew Reardon

CLO & Secretary, Ligand Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$10.3M

Companies

Latest trade

Oct 2, 2026

Companies

Ligand PharmaceuticalsCLO & Secretary −$10.3M

Trades

LGND Sold 5,000 shares at $304.07 · planned $1.5M Oct 2

LGND Sold 5,000 shares at $286.09 · planned $1.4M Sep 3

LGND Sold 5,000 shares at $288.99 · planned $1.4M Aug 3

LGND Sold 5,000 shares at $313.28 · planned $1.6M Jul 1

LGND Sold 5,000 shares at $227.06 · planned $1.1M Jun 1

LGND Sold 5,000 shares at $231.31 · planned $1.2M May 1

LGND Sold 5,000 shares at $201.24 · planned $1.0M Apr 1

LGND Sold 5,000 shares at $206.35 · planned $1.0M Mar 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.